{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:54:27Z","timestamp":1792011267975,"version":"4.4.0"},"reference-count":73,"publisher":"The Endocrine Society","issue":"9","funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1210\/en.2018-00466","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T10:33:31Z","timestamp":1535193211000},"page":"3268-3274","source":"Crossref","is-referenced-by-count":29,"title":["Vascular Endothelial FSH Receptor, a Target of Interest for Cancer Therapy"],"prefix":"10.1210","volume":"159","author":[{"given":"Nicolae","family":"Ghinea","sequence":"first","affiliation":[{"name":"Inserm-Tumor Angiogenesis Team, Translational Research Department, Curie Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20180825063327_B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5122(98)00072-3","article-title":"Follicle development during the normal menstrual cycle","volume":"30","author":"Macklon","year":"1998","journal-title":"Maturitas"},{"issue":"4","key":"key\n\t\t\t\t20180825063327_B2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/mend-4-4-525","article-title":"The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA","volume":"4","author":"Sprengel","year":"1990","journal-title":"Mol Endocrinol"},{"issue":"35","key":"key\n\t\t\t\t20180825063327_B3","doi-asserted-by":"crossref","first-page":"21411","DOI":"10.1016\/S0021-9258(18)45750-X","article-title":"Extracellular domain of lutropin\/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity","volume":"265","author":"Xie","year":"1990","journal-title":"J Biol Chem"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1073\/pnas.88.3.902","article-title":"Thyrotropin-luteinizing hormone\/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function","volume":"88","author":"Nagayama","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"key\n\t\t\t\t20180825063327_B5","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1074\/jbc.M114.549592","article-title":"Evidence for follicle-stimulating hormone receptor as a functional trimer","volume":"289","author":"Jiang","year":"2014","journal-title":"J Biol Chem"},{"issue":"5","key":"key\n\t\t\t\t20180825063327_B6","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/bi952290f","article-title":"Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor","volume":"35","author":"Vannier","year":"1996","journal-title":"Biochemistry"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biolcel.2003.11.008","article-title":"Receptor-mediated transcytosis of follicle-stimulating hormone through the rat testicular microvasculature","volume":"96","author":"Vu Hai","year":"2004","journal-title":"Biol Cell"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1095\/biolreprod.114.118562","article-title":"FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice","volume":"91","author":"Stilley","year":"2014","journal-title":"Biol Reprod"},{"issue":"7","key":"key\n\t\t\t\t20180825063327_B9","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/jc.2016-1014","article-title":"Functional expression of FSH receptor in endometriotic lesions","volume":"101","author":"Ponikwicka-Tyszko","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","article-title":"FSH directly regulates bone mass","volume":"125","author":"Sun","year":"2006","journal-title":"Cell"},{"issue":"7656","key":"key\n\t\t\t\t20180825063327_B11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature22342","article-title":"Blocking FSH induces thermogenic adipose tissue and reduces body fat","volume":"546","author":"Liu","year":"2017","journal-title":"Nature"},{"issue":"1","key":"key\n\t\t\t\t20180825063327_B12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2017.11.053","article-title":"Expression of FSHR in chondrocytes and the effect of FSH on chondrocytes","volume":"495","author":"Kong","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1097-0045(19980515)35:3<212::AID-PROS7>3.0.CO;2-I","article-title":"Coexpression of gonadotropic hormones and their corresponding FSH- and LH\/CG-receptors in the human prostate","volume":"35","author":"Dirnhofer","year":"1998","journal-title":"Prostate"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0022-5347(01)61831-7","article-title":"Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)","volume":"161","author":"Ben-Josef","year":"1999","journal-title":"J Urol"},{"issue":"6","key":"key\n\t\t\t\t20180825063327_B15","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0022-5347(06)00273-4","article-title":"Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer","volume":"175","author":"Mariani","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"key\n\t\t\t\t20180825063327_B16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/gyno.1999.5628","article-title":"Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone","volume":"76","author":"Zheng","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180825063327_B17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/molehr\/8.5.426","article-title":"FSH-regulated gene expression profiles in ovarian tumours and normal ovaries","volume":"8","author":"Chu","year":"2002","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ijc.10848","article-title":"Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems","volume":"103","author":"Wang","year":"2003","journal-title":"Int J Cancer"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/1078-0432.CCR-16-0492","article-title":"Follicle-stimulating hormone receptor is expressed by most ovarian cancer subtypes and is a safe and effective immunotherapeutic target","volume":"23","author":"Perales-Puchalt","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"10","key":"key\n\t\t\t\t20180825063327_B20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/2326-6066.CIR-15-0047","article-title":"Follicle\u2010stimulating hormone receptor as a target in the redirected T\u2010cell therapy for cancer","volume":"3","author":"Urbanska","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"key\n\t\t\t\t20180825063327_B21","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1039\/C3NR05042D","article-title":"Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells","volume":"6","author":"Modi","year":"2014","journal-title":"Nanoscale"},{"issue":"7","key":"key\n\t\t\t\t20180825063327_B22","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/0008-5472.CAN-05-1785","article-title":"Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells","volume":"66","author":"Choi","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/mp500766x","article-title":"PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging","volume":"12","author":"Hong","year":"2015","journal-title":"Mol Pharm"},{"issue":"4","key":"key\n\t\t\t\t20180825063327_B24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11307-013-0712-1","article-title":"Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging","volume":"16","author":"Xu","year":"2014","journal-title":"Mol Imaging Biol"},{"issue":"17","key":"key\n\t\t\t\t20180825063327_B25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1001283","article-title":"Expression of follicle-stimulating hormone receptor in tumor blood vessels","volume":"363","author":"Radu","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20180825063327_B26","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2559.2011.03848.x","article-title":"Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival","volume":"58","author":"Lenhard","year":"2011","journal-title":"Histopathology"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5603\/FHC.2012.0044","article-title":"Immunohistochemical detection of FSH receptors in pituitary adenomas and adrenal tumors","volume":"50","author":"Pawlikowski","year":"2012","journal-title":"Folia Histochem Cytobiol"},{"issue":"4","key":"key\n\t\t\t\t20180825063327_B28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5603\/EP.2013.0004","article-title":"Immunohistochemical detection of follicle stimulating hormone receptor (FSHR) in neuroendocrine tumours","volume":"64","author":"Pawlikowski","year":"2013","journal-title":"Endokrynol Pol"},{"issue":"6","key":"key\n\t\t\t\t20180825063327_B29","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.5114\/aoms.2015.56357","article-title":"Ectopic expression of follicle-stimulating hormone receptors in thyroid tumors","volume":"11","author":"Pawlikowski","year":"2015","journal-title":"Arch Med Sci"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B30","first-page":"174","article-title":"Ectopic expression of FSH receptor isoforms in neoplastic but not in endothelial cells from pancreatic neuroendocrine tumors","volume":"36","author":"Sardella","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"key\n\t\t\t\t20180825063327_B31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/his.12135","article-title":"Follicle-stimulating hormone receptor expression in soft tissue sarcomas","volume":"63","author":"Renner","year":"2013","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20180825063327_B32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mce.2016.08.009","article-title":"LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton","volume":"437","author":"Sanchez","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"key\n\t\t\t\t20180825063327_B33","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1582-4934.2011.01495.x","article-title":"Endothelial follicle stimulating hormone receptor in primary kidney cancer correlates with subsequent response to sunitinib","volume":"16","author":"Siraj","year":"2012","journal-title":"J Cell Mol Med"},{"issue":"1","key":"key\n\t\t\t\t20180825063327_B34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2407-13-246","article-title":"Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases","volume":"13","author":"Siraj","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"key\n\t\t\t\t20180825063327_B35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-015-0128-7","article-title":"Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery","volume":"34","author":"Planeix","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"key\n\t\t\t\t20180825063327_B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/antib6040015","article-title":"Antibody selection for cancer target validation of FSH-receptor in immunohistochemical settings","volume":"6","author":"M\u00f6ker","year":"2017","journal-title":"Antibodies (Basel)"},{"issue":"1-2","key":"key\n\t\t\t\t20180825063327_B37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0303-7207(96)03953-6","article-title":"The LH\/CG and FSH receptors: different molecular forms and intracellular traffic","volume":"125","author":"Misrahi","year":"1996","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1006\/bbrc.1996.1419","article-title":"Follitropin signal transduction: alternative splicing of the FSH receptor gene produces a dominant negative form of receptor which inhibits hormone action","volume":"226","author":"Sairam","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"key\n\t\t\t\t20180825063327_B39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/humupd\/8.5.413","article-title":"Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction","volume":"8","author":"Simoni","year":"2002","journal-title":"Hum Reprod Update"},{"issue":"1","key":"key\n\t\t\t\t20180825063327_B40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/endo.142.1.7886","article-title":"Hormone-induced receptor gene splicing: enhanced expression of the growth factor type I follicle-stimulating hormone receptor motif in the developing mouse ovary as a new paradigm in growth regulation","volume":"142","author":"Babu","year":"2001","journal-title":"Endocrinology"},{"issue":"6","key":"key\n\t\t\t\t20180825063327_B41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40291-016-0218-z","article-title":"Follicle-stimulating hormone receptor (FSHR): A promising tool in oncology","volume":"20","author":"Papadimitriou","year":"2016","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2605.1995.tb00391.x","article-title":"Quantification of androgen receptor and follicle-stimulating hormone receptor mRNA levels in human and monkey testes by a ribonuclease-protection assay","volume":"18","author":"Dankbar","year":"1995","journal-title":"Int J Androl"},{"issue":"7","key":"key\n\t\t\t\t20180825063327_B43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/molehr\/gau024","article-title":"Follicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSH","volume":"20","author":"Karakaya","year":"2014","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"key\n\t\t\t\t20180825063327_B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11307-013-0688-x","article-title":"Shifting focus in optical image-guided cancer therapy","volume":"16","author":"Keereweer","year":"2014","journal-title":"Mol Imaging Biol"},{"issue":"11","key":"key\n\t\t\t\t20180825063327_B45","first-page":"5935","article-title":"Monoclonal antibodies for the treatment of cancer","volume":"37","author":"Pento","year":"2017","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t20180825063327_B46","first-page":"915","volume-title":"Protides of the biological Fluids","author":"Dillman","year":"1982"},{"key":"key\n\t\t\t\t20180825063327_B47","first-page":"166","volume-title":"Frontiers of Radiation Therapy and Oncology","author":"Kemshead","year":"1990"},{"key":"key\n\t\t\t\t20180825063327_B48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.critrevonc.2018.03.014","article-title":"Cardiotoxic effects of chemotherapy: a review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system","volume":"126","author":"Babiker","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"key\n\t\t\t\t20180825063327_B49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"key\n\t\t\t\t20180825063327_B50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrc1627","article-title":"Tumour vascular targeting","volume":"5","author":"Neri","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20180825063327_B51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1078-0432.416.11.2","article-title":"Differentiation and definition of vascular-targeted therapies","volume":"11","author":"Siemann","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"6","key":"key\n\t\t\t\t20180825063327_B52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1628","article-title":"Disrupting tumour blood vessels","volume":"5","author":"Tozer","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.phrs.2005.10.006","article-title":"A review on pro- and anti-angiogenic factors as targets of clinical intervention","volume":"53","author":"Bou\u00efs","year":"2006","journal-title":"Pharmacol Res"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B54","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/ph3030572","article-title":"Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy","volume":"3","author":"Raica","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"key\n\t\t\t\t20180825063327_B55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/156800909789057006","article-title":"The role of fibroblast growth factors in tumor growth","volume":"9","author":"Korc","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"issue":"5422","key":"key\n\t\t\t\t20180825063327_B56","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"issue":"5299","key":"key\n\t\t\t\t20180825063327_B57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1126\/science.275.5299.482","article-title":"Designing therapies that target tumor blood vessels","volume":"275","author":"Barinaga","year":"1997","journal-title":"Science"},{"issue":"10043","key":"key\n\t\t\t\t20180825063327_B58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180825063327_B60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.vph.2017.01.001","article-title":"Targeting endothelial metabolism for anti-angiogenesis therapy: a pharmacological perspective","volume":"90","author":"Missiaen","year":"2017","journal-title":"Vascul Pharmacol"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-0642-03","article-title":"Vascular targeting agents as cancer therapeutics","volume":"10","author":"Thorpe","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"8","key":"key\n\t\t\t\t20180825063327_B62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/07357907.2017.1364745","article-title":"Realizing the potential of vascular targeted therapy: the rationale for combining vascular disrupting agents and anti-angiogenic agents to treat cancer","volume":"35","author":"Siemann","year":"2017","journal-title":"Cancer Invest"},{"key":"key\n\t\t\t\t20180825063327_B63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fonc.2013.00259","article-title":"Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents","volume":"3","author":"Cesca","year":"2013","journal-title":"Front Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180825063327_B64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.semradonc.2004.04.006","article-title":"The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure","volume":"14","author":"Milosevic","year":"2004","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"key\n\t\t\t\t20180825063327_B65","first-page":"765","article-title":"Neovasculature induced by vascular endothelial growth factor is fenestrated","volume":"57","author":"Roberts","year":"1997","journal-title":"Cancer Res"},{"issue":"4","key":"key\n\t\t\t\t20180825063327_B66","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","article-title":"Openings between defective endothelial cells explain tumor vessel leakiness","volume":"156","author":"Hashizume","year":"2000","journal-title":"Am J Pathol"},{"issue":"6976","key":"key\n\t\t\t\t20180825063327_B67","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/427695a","article-title":"Pathology: cancer cells compress intratumour vessels","volume":"427","author":"Padera","year":"2004","journal-title":"Nature"},{"issue":"2-3","key":"key\n\t\t\t\t20180825063327_B68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2007.05.003","article-title":"Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization","volume":"74","author":"Fukumura","year":"2007","journal-title":"Microvasc Res"},{"issue":"5","key":"key\n\t\t\t\t20180825063327_B69","first-page":"1144","article-title":"The first international conference on vascular targeting: meeting overview","volume":"63","author":"Thorpe","year":"2003","journal-title":"Cancer Res"},{"issue":"5299","key":"key\n\t\t\t\t20180825063327_B70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.275.5299.547","article-title":"Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature","volume":"275","author":"Huang","year":"1997","journal-title":"Science"},{"issue":"17","key":"key\n\t\t\t\t20180825063327_B71","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1158\/1078-0432.CCR-05-0389","article-title":"Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature","volume":"11","author":"Kessler","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2012.05.017","article-title":"Gonadotropin signalling in epithelial ovarian cancer","volume":"324","author":"Mertens-Walker","year":"2012","journal-title":"Cancer Lett"},{"issue":"2","key":"key\n\t\t\t\t20180825063327_B73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/erc.0.0110315","article-title":"FSH and LH serum\/tumor fluid ratios and malignant tumors of the ovary","volume":"11","author":"Rzepka-G\u00f3rska","year":"2004","journal-title":"Endocr Relat Cancer"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/9\/3268\/25542308\/en.2018-00466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T08:31:29Z","timestamp":1661848289000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/9\/3268\/5063419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":73,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,8,2]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2018-00466","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,8,2]]}}}